First Hawaiian Bank Sells 6,892 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

First Hawaiian Bank lowered its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 39.0% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 10,788 shares of the company’s stock after selling 6,892 shares during the period. First Hawaiian Bank’s holdings in Phibro Animal Health were worth $230,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Man Group plc acquired a new stake in Phibro Animal Health in the fourth quarter valued at $501,000. Barclays PLC grew its position in shares of Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock valued at $3,228,000 after buying an additional 29,271 shares during the last quarter. Lazard Asset Management LLC increased its stake in shares of Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock valued at $34,000 after buying an additional 1,589 shares during the period. Nuveen Asset Management LLC increased its stake in shares of Phibro Animal Health by 21.4% in the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock valued at $12,348,000 after buying an additional 103,618 shares during the period. Finally, Alliancebernstein L.P. raised its position in shares of Phibro Animal Health by 357.1% during the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company’s stock worth $2,730,000 after acquiring an additional 101,560 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on PAHC shares. Barclays upped their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Wall Street Zen raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Finally, Morgan Stanley lifted their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 8th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $20.00.

Phibro Animal Health Trading Down 0.3%

NASDAQ PAHC opened at $24.58 on Monday. The stock has a market capitalization of $996.33 million, a P/E ratio of 51.21, a P/E/G ratio of 0.45 and a beta of 0.62. The business has a 50 day simple moving average of $20.52 and a 200 day simple moving average of $21.85. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a one year low of $16.16 and a one year high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to analysts’ expectations of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Research analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 1.95%. Phibro Animal Health’s dividend payout ratio is currently 61.54%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.